⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 30 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 30 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT March 18, 2025

Nexviadyme 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung 100 mg (Pulver für ein Konzentrat zur Herstellung einer Infusionslösung)

📷 Wikipedia: Sanofi · Source
Nexviadyme 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung 100 mg (Pulver für ein Konzentrat zur Herstellung einer Infusionslösung)
📷 Wikipedia: Sanofi · Source
Nexviadyme 100 mg powder for a concentrate for solution for infusion 100 mg (powder for a concentrate for solution for infusion) Supply shortage due to manufacturing capacity issues. Affected packs: 10 vial box [unavailable since March 18, 2025]; 5 vial box [available].
🗄
Archived (older alert)
This alert was reported 546 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
120 days in total
May 18, 2026 September 15, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Nexviadyme is a powder used to make a drip medicine for people with a rare illness. It helps the body break down sugar.

What's happening? Some packs of this medicine are hard to find right now. The maker cannot make enough for a while.

Does this affect me? If you take this medicine in Austria, check if your pack is missing.

What should I do? Ask your pharmacist or doctor before changing anything. They can help find a solution.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: A16AB22 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sanofi B.V., Paasheuvelweg 25, 1105 BP Amsterdam, Niederlande · Affected packs: 5 Stück Schachtel, Durchstechflasche [verfügbar, since 2026-07-21, resupply 2026-09-02] · 10 Stück Schachtel, Durchstechflasche [Nicht verfügbar, since 2025-03-18]

First published
March 18, 2025
Last refreshed by us
2 weeks ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Nexviadyme 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung 100 mg (Pulver für ein Konzentrat zur Herstellung einer Infusionslösung). Nexviadyme 100 mg powder for a concentrate for solution for infusion 100 mg (powder for a concentrate for solution for infusion) Supply shortage due to manufacturing capacity issues. Affected packs: 10 vial box [unavailable since March 18, 2025]; 5 vial box [available].
When was this alert issued?
This alert was issued on March 18, 2025 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.